Kaleido Biosciences, Inc.·4

Nov 18, 4:07 PM ET

Korn Jerald 4

4 · Kaleido Biosciences, Inc. · Filed Nov 18, 2019

Insider Transaction Report

Form 4
Period: 2019-11-15
Korn Jerald
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-11-15+75,00075,000 total
    Exercise: $6.56Exp: 2029-11-14Common Stock (75,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest November 15, 2020, with the remaining 75% vesting in equal quarterly installments over the next three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION